BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 11564212)

  • 1. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
    Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
    Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
    Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
    Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
    Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
    J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis.
    Di Marco F; Terraneo S; Imeri G; Palumbo G; La Briola F; Tresoldi S; Volpi A; Gualandri L; Ghelma F; Alfano RM; Montanari E; Gorio A; Lesma E; Peron A; Canevini MP; Centanni S
    PLoS One; 2016; 11(5):e0155331. PubMed ID: 27171001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.
    Strizheva GD; Carsillo T; Kruger WD; Sullivan EJ; Ryu JH; Henske EP
    Am J Respir Crit Care Med; 2001 Jan; 163(1):253-8. PubMed ID: 11208653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
    Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ
    Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia.
    Hayashi T; Kumasaka T; Mitani K; Yao T; Suda K; Seyama K
    Mod Pathol; 2010 Sep; 23(9):1251-60. PubMed ID: 20526286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis of benign tumor cells in tuberous sclerosis complex.
    Henske EP
    Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronodular pneumocyte hyperplasia.
    Muir TE; Leslie KO; Popper H; Kitaichi M; Gagné E; Emelin JK; Vinters HV; Colby TV
    Am J Surg Pathol; 1998 Apr; 22(4):465-72. PubMed ID: 9537475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.
    Guo Y; Dreier JR; Cao J; Du H; Granter SR; Kwiatkowski DJ
    PLoS One; 2016; 11(12):e0167384. PubMed ID: 27907099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell "sugar" tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis.
    Flieder DB; Travis WD
    Am J Surg Pathol; 1997 Oct; 21(10):1242-7. PubMed ID: 9331299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological analysis of multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis in Japan.
    Kobashi Y; Sugiu T; Mouri K; Irei T; Nakata M; Oka M
    Respirology; 2008 Nov; 13(7):1076-81. PubMed ID: 18699800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.
    Carsillo T; Astrinidis A; Henske EP
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6085-90. PubMed ID: 10823953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis.
    Franz DN; Brody A; Meyer C; Leonard J; Chuck G; Dabora S; Sethuraman G; Colby TV; Kwiatkowski DJ; McCormack FX
    Am J Respir Crit Care Med; 2001 Aug; 164(4):661-8. PubMed ID: 11520734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
    Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
    J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.